| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
128 － ? |
N17 (Peptide)  |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
128 － ? |
NK27 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
C20 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
256 － ? |
I10 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK10 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK11 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK13 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK14 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK15 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
256 － ? |
NK19a (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK19b (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
256 － ? |
NK2 (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK22b (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK23a (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
>256 － ? |
NK23b (Peptide) |
923 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
512 － 1024 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1507 |
| Staphylococcus aureus (ATCC 43300) |
- |
- |
8192 － ? |
Clindamycin (Cleocin) |
1507 |
| Staphylococcus aureus (ATCC 5177) |
- |
- |
0.1 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
319 |
| Staphylococcus aureus (ATCC 5177) |
- |
- |
6.2 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
319 |
| Staphylococcus aureus (ATCC 5278) |
- |
- |
>100 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
319 |
| Staphylococcus aureus (ATCC 5278) |
- |
- |
>100 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
319 |
| Staphylococcus aureus (ATCC 6538) |
6.25 |
12.5 |
? － ? |
Silver nanoparticles |
776 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.045 |
? － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1044 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.045 |
? － ? |
Pradofloxacin (Veraflox) |
1044 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.0925 |
? － ? |
Enrofloxacin |
1044 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.125 |
? － ? |
Difloxacin |
1044 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.1875 |
? － ? |
Danofloxacin |
1044 |
| Staphylococcus aureus (ATCC 6538) |
- |
0.1875 |
? － ? |
Sarafloxacin |
1044 |